Free Trial

Envestnet Portfolio Solutions Inc. Sells 5,890 Shares of Procter & Gamble Company (The) $PG

Procter & Gamble logo with Consumer Staples background

Envestnet Portfolio Solutions Inc. lowered its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 3.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 166,511 shares of the company's stock after selling 5,890 shares during the quarter. Envestnet Portfolio Solutions Inc.'s holdings in Procter & Gamble were worth $26,528,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Nova Wealth Management Inc. bought a new stake in Procter & Gamble in the 1st quarter valued at $26,000. Signature Resources Capital Management LLC raised its stake in shares of Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock valued at $28,000 after purchasing an additional 72 shares during the period. Quarry LP bought a new stake in shares of Procter & Gamble in the first quarter valued at about $33,000. Mizuho Securities Co. Ltd. boosted its position in shares of Procter & Gamble by 566.7% during the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock worth $34,000 after buying an additional 170 shares during the period. Finally, RMG Wealth Management LLC bought a new position in shares of Procter & Gamble during the second quarter worth about $37,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on PG shares. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. Bank of America cut their price objective on shares of Procter & Gamble from $180.00 to $174.00 and set a "buy" rating on the stock in a research report on Wednesday, October 8th. Barclays decreased their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research report on Wednesday, October 1st. UBS Group cut their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating on the stock in a research report on Wednesday, October 8th. Finally, Evercore ISI restated an "in-line" rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, Procter & Gamble presently has a consensus rating of "Moderate Buy" and an average price target of $172.21.

Read Our Latest Analysis on Procter & Gamble

Procter & Gamble Stock Performance

Shares of PG stock opened at $147.54 on Tuesday. The company has a fifty day moving average price of $155.18 and a two-hundred day moving average price of $159.27. Procter & Gamble Company has a one year low of $146.96 and a one year high of $180.43. The stock has a market cap of $345.32 billion, a P/E ratio of 22.66, a P/E/G ratio of 3.97 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. During the same period in the prior year, the firm earned $1.40 EPS. Procter & Gamble's quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts predict that Procter & Gamble Company will post 6.91 EPS for the current year.

Insider Buying and Selling

In other Procter & Gamble news, CFO Andre Schulten sold 4,252 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $647,281.96. Following the completion of the transaction, the chief financial officer directly owned 53,992 shares of the company's stock, valued at $8,219,202.16. The trade was a 7.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of the company's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the transaction, the chief operating officer owned 46,899 shares in the company, valued at approximately $7,139,434.77. This represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 149,763 shares of company stock valued at $23,421,279. Insiders own 0.20% of the company's stock.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Big Market Shifts You Can’t Ignore: Where Investors Are Moving Now
3 Small-Cap Robotics Stocks with Massive Upside Ahead
The Rise of Aerial Robots: Drone Stocks Taking Off

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines